Statistics
Publications
9
Citations
564
H-Index
9
Active since
1997
D. Mark Hickinson is an author at AstraZeneca (United Kingdom) specializing in pharmacology, tyrosine kinase inhibitors, and medicine.
Publications per year
1997–2013
9
9
Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
Tim P. Green, Mike Fennell, Robin Whittaker et al. · Molecular Oncology · 2009 · 256 citations · Full text
Medicine, Oncology, Pharmacology +10
D. Mark Hickinson, Teresa Klinowska, Georgina Speake et al. · Clinical Cancer Research · 2010 · 120 citations
Medicine, Oncology, Pharmacology +17
Peter Ballard, Robert H. Bradbury, Laurent Hennequin et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 34 citations · Full text
Christopher J. Morrow, Mohammad A. Ghattas, Christopher G. Smith et al. · Cancer Research · 2010 · 26 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 9